alberta health and wellness drug benefit list · please review the alberta health and wellness drug...
TRANSCRIPT
Summary of Changes
to the
Alberta Health and Wellness
Drug Benefit List
Effective July 1, 2012
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
ABC 40211/81160 (R2012/07)
Inquiries should be directed to:
Pharmacy Services
Alberta Blue Cross
10009 108 Street NW
Edmonton AB T5J 3C5
Telephone Number: (780) 498-8370 (Edmonton)
(403) 294-4041 (Calgary)
1-800-361-9632 (Toll Free)
FAX Number: (780) 498-8384
1-877-828-4106 (Toll Free)
109BWebsite: Hhttp://www.health.alberta.ca/services/drug-benefit-list.html
Administered by Alberta Blue Cross
on behalf of Alberta Health and Wellness.
The Drug Benefit List (DBL) is a list of drugs for which
coverage may be provided to program participants. The DBL
is not intended to be, and must not be used as a diagnostic
or prescribing tool. Inclusion of a drug on the DBL does not
mean or imply that the drug is fit or effective for any specific
purpose. Prescribing professionals must always use their
professional judgment and should refer to product
monographs and any applicable practice guidelines when
prescribing drugs. The product monograph contains
information that may be required for the safe and effective
use of the product.
Copies of the Alberta Health and Wellness Drug Benefit List
Publication CD are available from Pharmacy Services,
Alberta Blue Cross at the address shown above.
Binder and contents: $42.00 ($40.00 + $2.00 G.S.T.)
Contents only: $36.75 ($35.00 + $1.75 G.S.T.)
A cheque or money order must accompany the request
for copies.
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012
Table of Contents
Restricted Benefits ..................................................................................................................................... 1
Drug Products(s) Added as Restricted Benefit(s) ........................................................................... 1
Multiple Sclerosis (MS) Benefits................................................................................................................. 1
Discontinued Multiple Sclerosis Benefit(s) ...................................................................................... 1
Least Cost Alternative (LCA) Price Change(s) .......................................................................................... 1
Discontinued Listing(s) ............................................................................................................................. 20
Product(s) Removed from the AHWDBL as Price Policy Requirements Not Satisfied ............................ 21
Please review the Alberta Health and Wellness Drug Benefit List in addition to this Summary of Changes
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012 1
Restricted Benefit(s)
Drug Product(s) Added as Restricted Benefit(s)
Trade Name / Strength / Form Generic Description DIN MFR
BLOOD GLUCOSE TEST STRIPS DIABETES SUPPLIES 00000999955 XXX
BLOOD LETTING LANCET DIABETES SUPPLIES 00000999941 XXX
INSULIN PEN NEEDLES DIABETES SUPPLIES 00000999985 XXX
INSULIN SYRINGES DIABETES SUPPLIES 00000999952 XXX
URINE TEST STRIPS DIABETES SUPPLIES 00000999957 XXX
Multiple Sclerosis (MS) Benefit(s)
Discontinued Multiple Sclerosis (MS) Benefit(s)
The following DIN(s) will be honored for claims processing by Alberta Blue Cross until July 31, 2012.
Trade Name / Strength / Form Generic Description DIN MFR
REBIF INIT PACK 8.8 MCG / 0.2 ML /
22 MCG / 0.5 ML INJECTION
SYRINGE
INTERFERON BETA-1A 00002281708 SRO
Least Cost Alternative (LCA) Price Change(s)
The following established IC Grouping(s) are affected and a revised LCA price has been established and will be
applied effective August 1, 2012.
Please review the online Alberta Health and Wellness Drug Benefit List at
http://www.health.alberta.ca/services/drug-benefit-list.html for further information.
Generic Description Strength / Form New LCA Price
ACEBUTOLOL HCL 100 MG TABLET 0.1298
ACEBUTOLOL HCL 200 MG TABLET 0.1947
ACEBUTOLOL HCL 400 MG TABLET 0.3875
ACYCLOVIR 200 MG TABLET 0.6397
ACYCLOVIR 400 MG TABLET 1.2700
ACYCLOVIR 800 MG TABLET 1.7848
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
2 EFFECTIVE JULY 1, 2012
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
ALENDRONATE SODIUM 10 MG TABLET 0.6911
ALENDRONATE SODIUM 70 MG TABLET 3.5835
ALFUZOSIN HCL 10 MG SUSTAINED-RELEASE
TABLET
0.4966
AMCINONIDE 0.1 % TOPICAL CREAM 0.2099
AMCINONIDE 0.1 % TOPICAL LOTION 0.3533
AMCINONIDE 0.1 % TOPICAL OINTMENT 0.4199
AMIODARONE HCL 200 MG TABLET 0.7747
AMLODIPINE BESYLATE 2.5 MG TABLET 0.2684
AMLODIPINE BESYLATE 5 MG TABLET 0.5052
AMLODIPINE BESYLATE 10 MG TABLET 0.7499
AMOXICILLIN TRIHYDRATE/
CLAVULANATE POTASSIUM
25 MG ORAL SUSPENSION 0.0517
AMOXICILLIN TRIHYDRATE/
CLAVULANATE POTASSIUM
50 MG ORAL SUSPENSION 0.0869
AMOXICILLIN TRIHYDRATE/
CLAVULANATE POTASSIUM
500 MG TABLET 0.6673
AMOXICILLIN TRIHYDRATE/
CLAVULANATE POTASSIUM
875 MG / 125 MG TABLET 0.8355
ATENOLOL 25 MG TABLET 0.1081
ATENOLOL 50 MG TABLET 0.2246
ATENOLOL/ CHLORTHALIDONE 50 MG TABLET 0.3195
ATENOLOL/ CHLORTHALIDONE 100 MG TABLET 0.5236
ATENOLOL 100 MG TABLET 0.3692
ATORVASTATIN CALCIUM 10 MG TABLET 0.6558
ATORVASTATIN CALCIUM 20 MG TABLET 0.8198
ATORVASTATIN CALCIUM 40 MG TABLET 0.8812
ATORVASTATIN CALCIUM 80 MG TABLET 0.8812
AZATHIOPRINE 50 MG TABLET 0.3724
AZITHROMYCIN 20 MG SUSPENSION 0.4090
AZITHROMYCIN 40 MG SUSPENSION 0.5796
AZITHROMYCIN 250 MG TABLET 1.8922
AZITHROMYCIN 600 MG TABLET 6.0000
BACLOFEN 10 MG TABLET 0.2517
BACLOFEN 20 MG TABLET 0.4898
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012 3
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
BENAZEPRIL HCL 5 MG TABLET 0.5995
BENAZEPRIL HCL 20 MG TABLET 0.8135
BENZYDAMINE HCL 0.15 % ORAL RINSE 0.0290
BETAHISTINE DIHYDROCHLORIDE 16 MG TABLET 0.1770
BETAMETHASONE DIPROPIONATE/
SALICYLIC ACID
0.5 MG TOPICAL LOTION 0.3698
BISOPROLOL FUMARATE 5 MG TABLET 0.1378
BISOPROLOL FUMARATE 10 MG TABLET 0.2284
BRIMONIDINE TARTRATE 0.2 % OPHTHALMIC SOLUTION 1.2418
BROMAZEPAM 3 MG TABLET 0.0575
BROMAZEPAM 6 MG TABLET 0.0841
BUPROPION HCL 100 MG SUSTAINED-RELEASE
TABLET
0.2103
BUPROPION HCL 150 MG SUSTAINED-RELEASE
TABLET
0.3275
BUSPIRONE HCL 10 MG TABLET 0.3723
CANDESARTAN CILEXETIL 8 MG TABLET 0.4455
CANDESARTAN CILEXETIL 16 MG TABLET 0.4455
CANDESARTAN CILEXETIL 32 MG TABLET 0.4455
CAPTOPRIL 12.5 MG TABLET 0.1325
CAPTOPRIL 25 MG TABLET 0.1875
CAPTOPRIL 50 MG TABLET 0.3494
CAPTOPRIL 100 MG TABLET 0.6497
CARBAMAZEPINE 100 MG CHEWABLE TABLET 0.0599
CARBAMAZEPINE 200 MG CHEWABLE TABLET 0.1181
CARBAMAZEPINE 200 MG SUSTAINED-RELEASE
TABLET
0.1467
CARBAMAZEPINE 400 MG SUSTAINED-RELEASE
TABLET
0.2933
CARVEDILOL 3.125 MG TABLET 0.4728
CARVEDILOL 6.25 MG TABLET 0.4728
CARVEDILOL 12.5 MG TABLET 0.4728
CARVEDILOL 25 MG TABLET 0.4728
CEFAZOLIN SODIUM 500 MG/VIAL INJECTION 2.5000
CEFAZOLIN SODIUM 1 G/VIAL INJECTION 3.7500
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
4 EFFECTIVE JULY 1, 2012
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
CEFAZOLIN SODIUM 10 G/VIAL INJECTION 35.0000
CEFPROZIL 25 MG ORAL SUSPENSION 0.0618
CEFPROZIL 50 MG ORAL SUSPENSION 0.1234
CEFPROZIL 250 MG TABLET 0.6319
CEFPROZIL 500 MG TABLET 1.2389
CEFTRIAXONE SODIUM 2 G/VIAL INJECTION 29.3125
CEFUROXIME AXETIL 250 MG TABLET 0.7237
CEFUROXIME AXETIL 500 MG TABLET 1.4337
CILAZAPRIL 1 MG TABLET 0.2492
CILAZAPRIL 2.5 MG TABLET 0.2755
CILAZAPRIL 5 MG TABLET 0.3201
CILAZAPRIL/
HYDROCHLOROTHIAZIDE
5 MG / 12.5 MG TABLET 0.4170
CIMETIDINE 600 MG TABLET 0.1702
CIMETIDINE 800 MG TABLET 0.2430
CIPROFLOXACIN HCL 0.3 % OPHTHALMIC SOLUTION 0.7639
CIPROFLOXACIN HCL 250 MG TABLET 0.9309
CIPROFLOXACIN HCL 500 MG TABLET 1.0503
CIPROFLOXACIN HCL 750 MG TABLET 1.9233
CITALOPRAM HYDROBROMIDE 20 MG TABLET 0.5011
CITALOPRAM HYDROBROMIDE 40 MG TABLET 0.5011
CLARITHROMYCIN 250 MG TABLET 0.5892
CLARITHROMYCIN 500 MG TABLET 1.6293
CLINDAMYCIN HCL 150 MG CAPSULE 0.3541
CLINDAMYCIN HCL 300 MG CAPSULE 0.7082
CLOBAZAM 10 MG TABLET 0.1537
CLOBETASOL 17-PROPIONATE 0.05 % TOPICAL CREAM 0.2470
CLOBETASOL 17-PROPIONATE 0.05 % SCALP LOTION 0.2156
CLOBETASOL 17-PROPIONATE 0.05 % TOPICAL OINTMENT 0.2470
CLOMIPRAMINE HCL 10 MG TABLET 0.1290
CLOMIPRAMINE HCL 25 MG TABLET 0.1758
CLOMIPRAMINE HCL 50 MG TABLET 0.3237
CLONAZEPAM 0.5 MG TABLET 0.0746
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012 5
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
CLONAZEPAM 1 MG TABLET 0.1487
CLONAZEPAM 2 MG TABLET 0.1286
CLONIDINE HCL 0.025 MG TABLET 0.2584
CLOPIDOGREL BISULFATE 75 MG TABLET 0.9279
CLOXACILLIN SODIUM 25 MG ORAL LIQUID 0.0898
CODEINE PHOSPHATE/
ACETAMINOPHEN/ CAFFEINE
15 MG TABLET 0.0807
CODEINE PHOSPHATE/
ACETAMINOPHEN/ CAFFEINE
30 MG TABLET 0.0798
CODEINE PHOSPHATE/
ACETAMINOPHEN
60 MG TABLET 0.1685
CYANOCOBALAMIN 1000 MCG / ML INJECTION 0.3060
CYCLOBENZAPRINE HCL 10 MG TABLET 0.3727
CYPROTERONE ACETATE 50 MG TABLET 1.4339
DEFEROXAMINE MESYLATE 500 MG / VIAL INJECTION 7.0600
DEFEROXAMINE MESYLATE 2 G / VIAL INJECTION 28.3500
DESMOPRESSIN ACETATE 0.1 MG TABLET 0.4973
DESMOPRESSIN ACETATE 0.2 MG TABLET 0.9945
DESMOPRESSIN ACETATE 10 MCG NASAL METERED
DOSE SPRAY
1.5222
DEXAMETHASONE 0.5 MG TABLET 0.1094
DEXAMETHASONE 4 MG TABLET 0.4263
DEXAMETHASONE SODIUM
PHOSPHATE
4 MG / ML INJECTION 1.6060
DICLOFENAC SODIUM 25 MG ENTERIC-COATED
TABLET
0.1189
DICLOFENAC SODIUM 50 MG ENTERIC-COATED
TABLET
0.3257
DICLOFENAC SODIUM 50 MG RECTAL SUPPOSITORY 0.4891
DICLOFENAC SODIUM 75 MG SUSTAINED-RELEASE
TABLET
0.4491
DICLOFENAC SODIUM 100 MG SUSTAINED-RELEASE
TABLET
0.6402
DICLOFENAC SODIUM 100 MG RECTAL SUPPOSITORY 0.6583
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
6 EFFECTIVE JULY 1, 2012
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
DIFLUNISAL 250 MG TABLET 0.5366
DILTIAZEM HCL 30 MG TABLET 0.1866
DILTIAZEM HCL 60 MG TABLET 0.3273
DILTIAZEM HCL 120 MG CONTROLLED-
DELIVERY CAPSULE
0.5157
DILTIAZEM HCL 180 MG CONTROLLED-
DELIVERY CAPSULE
0.6846
DILTIAZEM HCL 240 MG CONTROLLED-
DELIVERY CAPSULE
0.9080
DILTIAZEM HCL 300 MG CONTROLLED-
DELIVERY CAPSULE
1.1351
DILTIAZEM HCL 120 MG EXTENDED-RELEASE
CAPSULE
0.2987
DILTIAZEM HCL 180 MG EXTENDED-RELEASE
CAPSULE
0.4045
DILTIAZEM HCL 240 MG EXTENDED-RELEASE
CAPSULE
0.5365
DILTIAZEM HCL 300 MG EXTENDED-RELEASE
CAPSULE
0.6607
DILTIAZEM HCL 360 MG EXTENDED-RELEASE
CAPSULE
0.8089
DIVALPROEX SODIUM (VALPROIC
ACID EQUIV.)
125 MG ENTERIC-COATED
TABLET
0.1011
DIVALPROEX SODIUM (VALPROIC
ACID EQUIV.)
250 MG ENTERIC-COATED
TABLET
0.1817
DIVALPROEX SODIUM (VALPROIC
ACID EQUIV.)
500 MG ENTERIC-COATED
TABLET
0.3637
DOMPERIDONE MALEATE 10 MG TABLET 0.0886
DORZOLAMIDE HCL 2 % OPTHALMIC SOLUTION 1.3505
DORZOLAMIDE HCL/ TIMOLOL
MALEATE
2 % / 0.5 % OPTHALMIC
SOLUTION
2.0459
DOXAZOSIN MESYLATE 1 MG TABLET 0.2176
DOXAZOSIN MESYLATE 2 MG TABLET 0.2610
DOXAZOSIN MESYLATE 4 MG TABLET 0.3395
DOXEPIN HCL 25 MG CAPSULE 0.1576
DOXEPIN HCL 50 MG CAPSULE 0.2923
DOXEPIN HCL 75 MG CAPSULE 0.3916
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012 7
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
DOXEPIN HCL 100 MG CAPSULE 0.5160
ENALAPRIL MALEATE 2.5 MG TABLET 0.2731
ENALAPRIL MALEATE 5 MG TABLET 0.3231
ENALAPRIL MALEATE/
HYDROCHLOROTHIAZIDE
5 MG TABLET 0.4927
ENALAPRIL MALEATE 10 MG TABLET 0.3882
ENALAPRIL MALEATE 20 MG TABLET 0.4685
ENTACAPONE 200 MG TABLET 0.6095
ERYTHROMYCIN 250 MG CAPSULE (ENTERIC-
COATED PELLET)
0.4193
ERYTHROMYCIN 333 MG CAPSULE (ENTERIC-
COATED PELLET)
0.4657
ESTRADIOL-17B 50 MCG / DAY TRANSDERMAL
PATCH
2.1000
ESTRADIOL-17B 75 MCG / DAY TRANSDERMAL
PATCH
2.2375
ESTRADIOL-17B 100 MCG / DAY TRANSDERMAL
PATCH
2.3375
ETIDRONATE DISODIUM 200 MG TABLET 0.5161
ETIDRONATE DISODIUM/ CALCIUM
CARBONATE
400 MG TABLET 0.2221
FAMOTIDINE 20 MG TABLET 0.3882
FAMOTIDINE 40 MG TABLET 0.7089
FELODIPINE 5 MG EXTENDED-RELEASE
TABLET
0.4620
FELODIPINE 10 MG EXTENDED-RELEASE
TABLET
0.6733
FENOFIBRATE 100 MG TABLET 0.5407
FENOFIBRATE 160 MG CAPSULE 0.4488
FENOFIBRATE 200 MG CAPSULE 0.6806
FENTANYL 12 MCG / HR TRANSDERMAL
PATCH
2.2300
FENTANYL 25 MCG / HR TRANSDERMAL
PATCH
3.7188
FENTANYL 50 MCG / HR TRANSDERMAL
PATCH
7.0000
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
8 EFFECTIVE JULY 1, 2012
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
FENTANYL 75 MCG / HR TRANSDERMAL
PATCH
9.8438
FENTANYL 100 MCG / HR TRANSDERMAL
PATCH
12.2500
FINASTERIDE 5 MG TABLET 0.6714
FLECAINIDE ACETATE 50 MG TABLET 0.4253
FLECAINIDE ACETATE 100 MG TABLET 0.8505
FLUCONAZOLE 50 MG TABLET 1.8241
FLUCONAZOLE 100 MG TABLET 3.2354
FLUOXETINE HCL 10 MG CAPSULE 0.8650
FLUOXETINE HCL 20 MG CAPSULE 0.6920
FLURBIPROFEN 50 MG TABLET 0.2221
FLURBIPROFEN 100 MG TABLET 0.3039
FLUVOXAMINE MALEATE 50 MG TABLET 0.3063
FLUVOXAMINE MALEATE 100 MG TABLET 0.5506
FOSINOPRIL SODIUM 10 MG TABLET 0.3194
FOSINOPRIL SODIUM 20 MG TABLET 0.3841
FUROSEMIDE 20 MG TABLET 0.0373
FUROSEMIDE 40 MG TABLET 0.0558
GABAPENTIN 100 MG CAPSULE 0.1598
GABAPENTIN 300 MG CAPSULE 0.3887
GABAPENTIN 400 MG CAPSULE 0.4633
GALANTAMINE HYDROBROMIDE 8 MG EXTENDED-RELEASE
CAPSULE
1.8906
GALANTAMINE HYDROBROMIDE 16 MG EXTENDED-RELEASE
CAPSULE
1.8906
GALANTAMINE HYDROBROMIDE 24 MG EXTENDED-RELEASE
CAPSULE
1.8906
GEMFIBROZIL 300 MG CAPSULE 0.1853
GEMFIBROZIL 600 MG TABLET 0.5157
GLICLAZIDE 30 MG SUSTAINED-RELEASE
TABLET
0.1510
GLICLAZIDE 80 MG TABLET 0.1401
GRANISETRON HCL 1 MG TABLET 14.5125
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012 9
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
HYDROCHLOROTHIAZIDE/
SPIRONOLACTONE
25 MG TABLET 0.1216
HYDROCHLOROTHIAZIDE/
SPIRONOLACTONE
50 MG TABLET 0.2571
HYDROCHLOROTHIAZIDE/
AMILORIDE HCL
50 MG TABLET 0.1293
HYDROCORTISONE/ CINCHOCAINE
HCL/ FRAMYCETIN SULFATE/
ESCULIN
5 MG RECTAL OINTMENT 0.4000
HYDROCORTISONE/ CINCHOCAINE
HCL/ FRAMYCETIN SULFATE/
ESCULIN
5 MG RECTAL SUPPOSITORY 0.6000
HYDROCORTISONE ACETATE/ ZINC
SULFATE
0.5 % RECTAL OINTMENT 0.3850
HYDROCORTISONE ACETATE/ ZINC
SULFATE
10 MG RECTAL SUPPOSITORY 0.5833
HYDROCORTISONE SODIUM
SUCCINATE
100 MG / VIAL INJECTION 2.3000
HYDROCORTISONE SODIUM
SUCCINATE
250 MG / VIAL INJECTION 3.9100
HYDROCORTISONE SODIUM
SUCCINATE
500 MG / VIAL INJECTION 5.8650
HYDROCORTISONE SODIUM
SUCCINATE
1 G / VIAL INJECTION 9.8900
HYDROMORPHONE HCL 2 MG TABLET 0.1416
HYDROMORPHONE HCL 2 MG / ML INJECTION 0.9450
HYDROMORPHONE HCL 10 MG / ML INJECTION 2.7860
HYDROXYCHLOROQUINE SULFATE 200 MG TABLET 0.2620
IBUPROFEN 400 MG TABLET 0.0474
IBUPROFEN 600 MG TABLET 0.4422
INDAPAMIDE HEMIHYDRATE 1.25 MG TABLET 0.1173
INDAPAMIDE HEMIHYDRATE 2.5 MG TABLET 0.1833
INDOMETHACIN 100 MG RECTAL SUPPOSITORY 0.8910
IPRATROPIUM BROMIDE 125 MCG INHALATION UNIT
DOSE SOLUTION
0.3295
IPRATROPIUM BROMIDE 250 MCG INHALATION
SOLUTION
0.3456
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
10 EFFECTIVE JULY 1, 2012
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
IPRATROPIUM BROMIDE 250 MCG INHALATION UNIT
DOSE SOLUTION
0.6590
IPRATROPIUM BROMIDE/
SALBUTAMOL SULFATE
0.2 MG INHALATION SOLUTION 0.2936
IRBESARTAN 75 MG TABLET 0.4422
IRBESARTAN 150 MG TABLET 0.4422
IRBESARTAN 300 MG TABLET 0.4422
IRBESARTAN/
HYDROCHLOROTHIAZIDE
300 MG TABLET 0.4422
IRBESARTAN/
HYDROCHLOROTHIAZIDE
150 MG / 12.5 MG TABLET 0.4422
IRBESARTAN/
HYDROCHLOROTHIAZIDE
300 MG / 25 MG TABLET 0.4205
ISOSORBIDE-5-MONONITRATE 60 MG EXTENDED-RELEASE
TABLET
0.3523
ISOTRETINOIN 10 MG CAPSULE 0.9313
ISOTRETINOIN 40 MG CAPSULE 1.9003
KETOCONAZOLE 200 MG TABLET 0.9393
KETOROLAC TROMETHAMINE 0.5 % OPHTHALMIC SOLUTION 1.6000
LAMOTRIGINE 25 MG TABLET 0.1438
LAMOTRIGINE 100 MG TABLET 0.5739
LAMOTRIGINE 150 MG TABLET 0.8458
LANSOPRAZOLE 15 MG DELAYED-RELEASE
CAPSULE
0.7000
LANSOPRAZOLE 30 MG DELAYED-RELEASE
CAPSULE
0.7000
LATANOPROST 0.005 % OPHTHALMIC
SOLUTION
4.1427
LEFLUNOMIDE 10 MG TABLET 4.1027
LEFLUNOMIDE 20 MG TABLET 4.1046
LEVETIRACETAM 500 MG TABLET 0.9750
LEVETIRACETAM 750 MG TABLET 1.3500
LEVETIRACETAM 250 MG TABLET 0.8000
LEVOBUNOLOL HCL 0.25 % OPHTHALMIC SOLUTION 0.9320
LEVOBUNOLOL HCL 0.5 % OPHTHALMIC SOLUTION 1.2379
LEVODOPA/ CARBIDOPA 100 MG TABLET 0.1877
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012 11
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
LEVODOPA/ CARBIDOPA 100 MG TABLET 0.2803
LEVODOPA/ CARBIDOPA 100 MG / 25 MG SUSTAINED-
RELEASE TABLET
0.5510
LEVODOPA/ CARBIDOPA 250 MG / 25 MG TABLET 0.3129
LEVOFLOXACIN 250 MG TABLET 1.8655
LEVOFLOXACIN 500 MG TABLET 2.1050
LEVOFLOXACIN 750 MG TABLET 4.8478
LISINOPRIL 5 MG TABLET 0.2094
LISINOPRIL 10 MG TABLET 0.2516
LISINOPRIL/
HYDROCHLOROTHIAZIDE
10 MG TABLET 0.3256
LISINOPRIL 20 MG TABLET 0.3026
LISINOPRIL/
HYDROCHLOROTHIAZIDE
20 MG TABLET 0.3913
LISINOPRIL/
HYDROCHLOROTHIAZIDE
20 MG TABLET 0.3506
LISINOPRIL/
HYDROCHLOROTHIAZIDE
20 MG TABLET 0.3913
LITHIUM CARBONATE 150 MG CAPSULE 0.0449
LITHIUM CARBONATE 300 MG CAPSULE 0.0443
LOSARTAN POTASSIUM 25 MG TABLET 0.4407
LOSARTAN POTASSIUM 50 MG TABLET 0.4407
LOSARTAN POTASSIUM/
HYDROCHLOROTHIAZIDE
50 MG TABLET 0.4407
LOSARTAN POTASSIUM 100 MG TABLET 0.4407
LOSARTAN POTASSIUM/
HYDROCHLOROTHIAZIDE
100 MG TABLET 0.4407
LOSARTAN POTASSIUM/
HYDROCHLOROTHIAZIDE
100 MG TABLET 0.4314
LOVASTATIN 20 MG TABLET 0.7213
LOVASTATIN 40 MG TABLET 1.3176
L-TRYPTOPHAN 500 MG CAPSULE 0.3563
L-TRYPTOPHAN 500 MG TABLET 0.3563
L-TRYPTOPHAN 1 G TABLET 0.7126
MEDROXYPROGESTERONE
ACETATE
2.5 MGTABLET 0.0615
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
12 EFFECTIVE JULY 1, 2012
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
MEDROXYPROGESTERONE
ACETATE
5 MG TABLET 0.1216
MEDROXYPROGESTERONE
ACETATE
10 MG TABLET 0.2468
METFORMIN HCL 500 MG TABLET 0.1022
METFORMIN HCL 850 MG TABLET 0.1331
METHYLPHENIDATE HCL 10 MG TABLET 0.1331
METHYLPHENIDATE HCL 20 MG EXTENDED-RELEASE
TABLET
0.2820
METHYLPHENIDATE HCL 20 MG TABLET 0.2326
METHYLPREDNISOLONE ACETATE 40 MG / ML INJECTION 4.1000
METHYLPREDNISOLONE ACETATE 80 MG / ML INJECTION 8.2000
METHYLPREDNISOLONE ACETATE
(PRESERVED)
40 MG / ML INJECTION 4.1000
METHYLPREDNISOLONE SODIUM
SUCCINATE
40 MG / VIAL INJECTION 3.9600
METHYLPREDNISOLONE SODIUM
SUCCINATE
125 MG / VIAL INJECTION 9.3500
METHYLPREDNISOLONE SODIUM
SUCCINATE
500 MG / VIAL INJECTION 22.2002
METHYLPREDNISOLONE SODIUM
SUCCINATE
1 G / VAIL INJECTION 34.1000
METOPROLOL TARTRATE 50 MG TABLET 0.1047
METOPROLOL TARTRATE 100 MG TABLET 0.2147
METOPROLOL TARTRATE 100 MG SUSTAINED-RELEASE
TABLET
0.1312
METOPROLOL TARTRATE 200 MG SUSTAINED-RELEASE
TABLET
0.2499
METRONIDAZOLE 5 MG/ML INJECTION 0.1869
MINOCYCLINE HCL 50 MG CAPSULE 0.3344
MINOCYCLINE HCL 100 MG CAPSULE 0.6458
MIRTAZAPINE 15 MG TABLET 0.2344
MIRTAZAPINE 30 MG TABLET 0.4546
MOCLOBEMIDE 150 MG TABLET 0.2279
MOCLOBEMIDE 300 MG TABLET 0.4476
MODAFINIL 100 MG TABLET 0.9990
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012 13
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
MOMETASONE FUROATE 0.1 % TOPICAL CREAM 0.2379
MOMETASONE FUROATE 0.1 % TOPICAL OINTMENT 0.2253
MONTELUKAST SODIUM 4 MG CHEWABLE TABLET 0.5216
MONTELUKAST SODIUM 4 MG ORAL GRANULE 0.5216
MONTELUKAST SODIUM 5 MG CHEWABLE TABLET 0.5776
MONTELUKAST SODIUM 10 MG TABLET 0.8483
MORPHINE SULFATE 15 MG SUSTAINED-RELEASE
TABLET
0.2559
MORPHINE SULFATE 30 MG SUSTAINED-RELEASE
TABLET
0.3872
MORPHINE SULFATE 60 MG SUSTAINED-RELEASE
TABLET
0.6822
MORPHINE SULFATE 100 MG SUSTAINED-RELEASE
TABLET
1.0400
MORPHINE SULFATE 200 MG SUSTAINED-RELEASE
TABLET
1.9335
NABILONE 0.5 MG CAPSULE 1.1674
NABILONE 1 MG CAPSULE 2.3346
NABUMETONE 500 MG TABLET 0.3625
NAPROXEN 250 MG ENTERIC-COATED
TABLET
0.1570
NAPROXEN 375 MG ENTERIC-COATED
TABLET
0.2062
NAPROXEN 500 MG ENTERIC-COATED
TABLET
0.3718
NARATRIPTAN HCL 1 MG TABLET 8.4338
NARATRIPTAN HCL 2.5 MG TABLET 6.1437
NIFEDIPINE 30 MG EXTENDED-RELEASE
TABLET
0.6171
NIFEDIPINE 60 MG EXTENDED-RELEASE
TABLET
0.9374
NITRAZEPAM 5 MG TABLET 0.0500
NITRAZEPAM 10 MG TABLET 0.0748
NIZATIDINE 150 MG CAPSULE 0.3566
NIZATIDINE 300 MG CAPSULE 0.6347
NORFLOXACIN 400 MG TABLET 0.7628
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
14 EFFECTIVE JULY 1, 2012
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
NORTRIPTYLINE HCL 10 MG CAPSULE 0.0893
NORTRIPTYLINE HCL 25 MG CAPSULE 0.1804
OCTREOTIDE ACETATE 50 MCG / ML INJECTION 1.9076
OCTREOTIDE ACETATE 100 MCG / ML INJECTION 3.6007
OCTREOTIDE ACETATE 200 MCG/ML INJECTION 6.9268
OCTREOTIDE ACETATE 500 MCG/ML INJECTION 16.9230
OFLOXACIN 0.3 % OPHTHALMIC SOLUTION 0.9203
OLANZAPINE 2.5 MG TABLET 0.6762
OLANZAPINE 5 MG DISINTEGRATING TABLET 1.3449
OLANZAPINE 5 MG TABLET 1.3524
OLANZAPINE 7.5 MG TABLET 2.0286
OLANZAPINE 10 MG DISINTEGRATING
TABLET
2.6875
OLANZAPINE 10 MG TABLET 2.7048
OLANZAPINE 15 MG TABLET 4.0571
OMEPRAZOLE 20 MG CAPSULE / SUSTAINED
RELEASE TABLET
0.7700
ONDANSETRON HCL DIHYDRATE 2 MG / ML INJECTION 3.7143
ONDANSETRON HCL DIHYDRATE 2 MG / ML INJECTION 3.7143
ONDANSETRON HCL DIHYDRATE 4 MG TABLET 5.0410
ONDANSETRON HCL DIHYDRATE 8 MG TABLET 7.6921
ONDANSETRON HCL DIHYDRATE 0.8 MG SOLUTION 1.5710
OXYBUTYNIN CHLORIDE 5 MG TABLET 0.1553
OXYCODONE HCL 5 MG TABLET 0.1287
OXYCODONE HCL 10 MG TABLET 0.1896
OXYCODONE HCL 20 MG TABLET 0.2964
PAMIDRONATE DISODIUM 60 MG / VIAL INJECTION 176.7000
PANTOPRAZOLE 40 MG ENTERIC-COATED
TABLET
0.7827
PAROXETINE HCL 20 MG TABLET 0.6794
PAROXETINE HCL 30 MG TABLET 0.7218
PENICILLIN V POTASSIUM 60 MG ORAL LIQUID 0.0472
PINDOLOL 5 MG TABLET 0.2147
PINDOLOL 10 MG TABLET 0.3666
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012 15
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
PINDOLOL 15 MG TABLET 0.5318
PIOGLITAZONE HCL 15 MG TABLET 0.8718
PIOGLITAZONE HCL 30 MG TABLET 1.2214
PIOGLITAZONE HCL 45 MG TABLET 1.8365
PIROXICAM 10 MG CAPSULE 0.3210
PIROXICAM 20 MG CAPSULE 0.5195
PRAMIPEXOLE DIHYDROCHLORIDE 0.25 MG TABLET 0.3679
PRAMIPEXOLE DIHYDROCHLORIDE 1 MG TABLET 0.7360
PRAMIPEXOLE DIHYDROCHLORIDE 1.5 MG TABLET 0.7360
PRAVASTATIN SODIUM 10 MG TABLET 0.5956
PRAVASTATIN SODIUM 20 MG TABLET 0.7027
PRAVASTATIN SODIUM 40 MG TABLET 0.8464
PRAZOSIN HCL 1 MG TABLET 0.1371
PRAZOSIN HCL 2 MG TABLET 0.1862
PRAZOSIN HCL 5 MG TABLET 0.2560
PREDNISOLONE SODIUM
PHOSPHATE
1 MG ORAL LIQUID 0.0478
QUETIAPINE FUMARATE 25 MG TABLET 0.1932
QUETIAPINE FUMARATE 100 MG TABLET 0.5155
QUETIAPINE FUMARATE 200 MG TABLET 1.0354
QUETIAPINE FUMARATE 300 MG TABLET 1.5105
QUININE SULFATE 300 MG CAPSULE 0.2888
RABEPRAZOLE SODIUM 10 MG ENTERIC-COATED
TABLET
0.2517
RABEPRAZOLE SODIUM 20 MG ENTERIC-COATED
TABLET
0.5033
RALOXIFENE HCL 60 MG TABLET 0.8457
RAMIPRIL 1.25 MG CAPSULE / TABLET 0.2663
RAMIPRIL 2.5 MG CAPSULE / TABLET 0.3073
RAMIPRIL 5 MG CAPSULE / TABLET 0.3073
RAMIPRIL 10 MG CAPSULE / TABLET 0.3892
RANITIDINE HCL 15 MG ORL SOLUTION 0.0932
REPAGLINIDE 0.5 MG TABLET 0.1094
REPAGLINIDE 1 MG TABLET 0.1138
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
16 EFFECTIVE JULY 1, 2012
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
REPAGLINIDE 2 MG TABLET 0.1182
RISEDRONATE SODIUM 5 MG TABLET 1.3897
RISEDRONATE SODIUM 30 MG TABLET 9.0033
RISEDRONATE SODIUM 35 MG TABLET 3.9224
RISPERIDONE 0.25 MG TABLET 0.2035
RISPERIDONE 0.5 MG TABLET 0.3409
RISPERIDONE 1 MG TABLET 0.4710
RISPERIDONE 2 MG TABLET 0.9402
RISPERIDONE 3 MG DISINTEGRATING TABLET 2.1913
RISPERIDONE 3 MG TABLET 1.4104
RISPERIDONE 4 MG TABLET 1.8807
RISPERIDONE TARTRATE 1 MG ORL SOLUTION 0.5312
RIVASTIGMINE HYDROGEN
TARTRATE
1.5 MG CAPSULE 0.9805
RIVASTIGMINE HYDROGEN
TARTRATE
3 MG CAPSULE 0.9805
RIVASTIGMINE HYDROGEN
TARTRATE
4.5 MG CAPSULE 0.9805
RIVASTIGMINE HYDROGEN
TARTRATE
6 MG CAPSULE 0.9805
RIZATRIPTAN BENZOATE 5 MG DISINTEGRATING TABLET 5.3270
RIZATRIPTAN BENZOATE 10 MG DISINTEGRATING
TABLET
5.3270
ROPINIROLE HCL 1 MG TABLET 0.4271
ROPINIROLE HCL 0.25 MG TABLET 0.1068
ROPINIROLE HCL 2 MG TABLET 0.4699
ROPINIROLE HCL 5 MG TABLET 1.2937
ROSUVASTATIN CALCIUM 5 MG TABLET 0.4854
ROSUVASTATIN CALCIUM 10 MG TABLET 0.5117
ROSUVASTATIN CALCIUM 20 MG TABLET 0.6396
ROSUVASTATIN CALCIUM 40 MG TABLET 0.7487
SALBUTAMOL SULFATE 0.5 MG INHALATION SOLUTION 0.1074
SALBUTAMOL SULFATE 1 MG INHALATION SOLUTION 0.1555
SALBUTAMOL SULFATE 2 MG INHALATION UNIT DOSE
SOLUTION
0.2954
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012 17
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
SALBUTAMOL SULFATE 5 MG INHALATION SOLUTION 0.3774
SELEGILINE HCL 5 MG TABLET 0.7906
SERTRALINE HCL 25 MG CAPSULE 0.3169
SERTRALINE HCL 50 MG CAPSULE 0.6337
SERTRALINE HCL 100 MG CAPSULE 0.6641
SIMVASTATIN 5 MG TABLET 0.3704
SIMVASTATIN 10 MG TABLET 0.7287
SIMVASTATIN 20 MG TABLET 0.9005
SIMVASTATIN 40 MG TABLET 0.9005
SIMVASTATIN 80 MG TABLET 0.9005
SOTALOL HCL 80 MG TABLET 0.3708
SOTALOL HCL 160 MG TABLET 0.4058
SPIRONOLACTONE 25 MG TABLET 0.1194
SPIRONOLACTONE 100 MG TABLET 0.2780
SULINDAC 200 MG TABLET 0.3920
SUCRALFATE 1 G TABLET 0.2148
SUMATRIPTAN SUCCINATE 6 MG INJECTION SYRINGE 16.5889
SUMATRIPTAN SUCCINATE 50 MG TABLET 7.1350
SUMATRIPTAN SUCCINATE 100 MG TABLET 7.8600
SYNTHETIC CALCITONIN SALMON
(SALCATONIN)
200 IU NASAL METERED DOSE
SPRAY
1.4000
TAMSULOSIN HCL 0.4 MG EXTENDED-RELEASE
TABLET
0.2100
TAMSULOSIN HCL 0.4 MG SUSTAINED-RELEASE
CAPSULE
0.3415
TELMISARTAN 40 MG TABLET 0.4080
TELMISARTAN 80 MG TABLET 0.4080
TELMISARTAN/
HYDROCHLOROTHIAZIDE
80 MG / 12.5 MGTABLET 0.4080
TELMISARTAN/
HYDROCHLOROTHIAZIDE
80 MG / 25 MGTABLET 0.4080
TEMAZEPAM 15 MG CAPSULE 0.0730
TEMAZEPAM 30 MG CAPSULE 0.0883
TERAZOSIN HCL 1 MG TABLET 0.2563
TERAZOSIN HCL 2 MG TABLET 0.3258
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
18 EFFECTIVE JULY 1, 2012
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
TERAZOSIN HCL 5 MG TABLET 0.4425
TERAZOSIN HCL 10 MG TABLET 0.6477
TERBINAFINE HCL 250 MG TABLET 1.8525
TIAPROFENIC ACID 300 MG TABLET 0.3257
TICLOPIDINE HCL 250 MG TABLET 0.4303
TIMOLOL MALEATE 0.25 % OPHTHALMIC SOLUTION 0.9688
TIMOLOL MALEATE 5 MG TABLET 0.1649
TIMOLOL MALEATE 10 MG TABLET 0.2572
TIMOLOL MALEATE 20 MG TABLET 0.5005
TIZANIDINE HCL 4 MG TABLET 0.3686
TOBRAMYCIN 0.3 % OPHTHALMIC SOLUTION 0.6560
TOPIRAMATE 25 MG TABLET 0.4811
TOPIRAMATE 100 MG TABLET 0.9119
TOPIRAMATE 200 MG TABLET 1.3616
TRAZODONE HCL 50 MG TABLET 0.1384
TRAZODONE HCL 100 MG TABLET 0.2473
TRAZODONE HCL 150 MG TABLET 0.3633
TRIAMCINOLONE ACETONIDE 10 MG / ML INJECTION 2.4500
TRIAMCINOLONE ACETONIDE 40 MG / ML INJECTION 4.7700
TRIFLURIDINE 1 % OPHTHALMIC SOLUTION 3.0387
TRIMEBUTINE MALEATE 200 MG TABLET 0.5628
VALACYCLOVIR 500 MG TABLET 1.2765
VALPROIC ACID 250 MG CAPSULE 0.1908
VALPROIC ACID 50 MG ORAL SYRUP 0.0398
VALSARTAN 80 MG TABLET 0.4514
VALSARTAN 160 MG TABLET 0.4512
VALSARTAN 320 MG TABLET 0.4347
VALSARTAN/
HYDROCHLOROTHIAZIDE
160 MG TABLET 0.4504
VALSARTAN/
HYDROCHLOROTHIAZIDE
160 MG TABLET 0.4519
VALSARTAN/
HYDROCHLOROTHIAZIDE
320 MG TABLET 0.4452
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012 19
Least Cost Alternative (LCA) Price Change(s), continued
Generic Description Strength / Form New LCA Price
VALSARTAN/
HYDROCHLOROTHIAZIDE
320 MG TABLET 0.4452
VALSARTAN/
HYDROCHLOROTHIAZIDE
80 MG / 12.5 MG TABLET 0.4452
VENLAFAXINE HCL 37.5 MG EXTENDED-RELEASE
CAPSULE
0.3477
VENLAFAXINE HCL 75 MG EXTENDED-RELEASE
CAPSULE
0.6956
VENLAFAXINE HCL 150 MG EXTENDED-RELEASE
CAPSULE
0.7343
VERAPAMIL HCL 120 MG SUSTAINED-RELEASE
TABLET
0.5078
VERAPAMIL HCL 180 MG SUSTAINED-RELEASE
TABLET
0.5315
VERAPAMIL HCL 240 MG SUSTAINED-RELEASE
TABLET
0.7088
WARFARIN SODIUM 1 MG TABLET 0.1147
WARFARIN SODIUM 2 MG TABLET 0.1213
WARFARIN SODIUM 2.5 MG TABLET 0.0971
WARFARIN SODIUM 3 MG TABLET 0.1504
WARFARIN SODIUM 4 MG TABLET 0.1504
WARFARIN SODIUM 5 MG TABLET 0.0973
WARFARIN SODIUM 10 MG TABLET 0.1746
ZOLMITRIPTAN 2.5 MG DISPERSIBLE TABLET 5.2110
ZOLMITRIPTAN 2.5 MG TABLET 5.2110
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
20 EFFECTIVE JULY 1, 2012
Discontinued Listing(s)
The following DIN(s) will be honored for claims processing by Alberta Blue Cross until July 31, 2012.
Trade Name / Strength / Form Generic Description DIN MFR
5-AMINOSALICYLIC ACID 400 MG
ENTERIC-COATED TABLET
MESALAZINE 00002351463 SNS
APO-BENZYDAMINE 0.15 % ORAL
RINSE
BENZYDAMINE HCL 00002239044 APX
APO-CARBAMAZEPINE 200 MG
TABLET
CARBAMAZEPINE 00000402699 APX
APO-CLONIDINE 0.2 MG TABLET CLONIDINE HCL 00000868957 APX
APO-INDOMETHACIN 25 MG
CAPSULE
INDOMETHACIN 00000611158 APX
APO-INDOMETHACIN 50 MG
CAPSULE
INDOMETHACIN 00000611166 APX
APO-METOCLOP 5 MG TABLET METOCLOPRAMIDE HCL 00000842826 APX
APO-METOCLOP 10 MG TABLET METOCLOPRAMIDE HCL 00000842834 APX
EUGLUCON 5 MG TABLET GLYBURIDE 00000720941 PMS
HEPARIN LOCK FLUSH 10 IU / ML
INJECTION USP
HEPARIN SODIUM 00000725323 HSP
HEPARIN LOCK FLUSH 100 IU / ML
INJECTION USP
HEPARIN SODIUM 00000725315 HSP
MYLAN-TIMOLOL 0.25% OPH
SOLUTION
TIMOLOL MALEATE 00000893773 MYP
PRAMIPEXOLE 1 MG TABLET PRAMIPEXOLE
DIHYDROCHLORIDE
00002367629 SNS
PRAMIPEXOLE 1.5 MG TABLET PRAMIPEXOLE
DIHYDROCHLORIDE
00002367645 SNS
RAN-TAMSULOSIN 0.4 MG
SUSTAINED-RELEASE CAPSULE
TAMSULOSIN HCL 00002294885 RAN
RATIO-CODEINE 5 MG / ML ORAL
SYRUP
CODEINE PHOSPHATE 00000779474 RPH
SOLU-MEDROL ACT-O-VIAL (PRES)
40 MG / VIAL (BASE) INJECTION
METHYLPREDNISOLONE
SODIUM SUCCINATE
00002063719 PFI
SOLU-MEDROL ACT-O-VIAL (PRES)
125 MG / VIAL (BASE) INJECTION
METHYLPREDNISOLONE
SODIUM SUCCINATE
00002063727 PFI
SOLU-MEDROL ACT-O-VIAL (PRES)
500 MG / VIAL (BASE) INJECTION
METHYLPREDNISOLONE
SODIUM SUCCINATE
00002063700 PFI
TAMSULOSIN 0.4 MG SUSTAINED-
RELEASE CAPSULE
TAMSULOSIN HCL 00002331780 RAN
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012 21
Product(s) Removed from the AHWDBL as Price Policy
Requirements Not Satisfied
The Alberta government-sponsored drug programs previously covered the following drug product(s). Effective
July 1, 2012, the listed product(s) will no longer be a benefit and will not be considered for coverage by special
authorization. A transition period will be applied and, as of July 31, 2012, claims will no longer pay for these
products.
Trade Name / Strength / Form Generic Description DIN MFR
APO-DORZOLAMIDE 2%
OPHTHALMIC SOLUTION
DORZOLAMIDE HCL 00002296055 APX
APO-LISINOPRIL/ HCTZ 20 MG / 25
MG TABLET
LISINOPRIL/
HYDROCHLOROTHIAZIDE
00002261995 APX
APO-MEDROXY 2.5 MG TABLET MEDROXYPROGESTERONE
ACETATE
00002244726 APX
APO-MEDROXY 5 MG TABLET MEDROXYPROGESTERONE
ACETATE
00002244727 APX
APO-MEDROXY 10 MG TABLET MEDROXYPROGESTERONE
ACETATE
00002277298 APX
APO-METFORMIN 850 MG TABLET METFORMIN HCL 00002229785 APX
APO-METHYLPHENIDATE 20 MG
TABLET
METHYLPHENIDATE HCL 00002249332 APX
AVA-ATENOLOL 25 MG TABLET ATENOLOL 00002360969 AVA
AVA-BISOPROLOL 5 MG TABLET BISOPROLOL FUMARATE 00002363887 AVA
AVA-BUPROPION SR 100 MG
SUSTAINED-RELEASE TABLET
BUPROPION HCL 00002363399 AVA
AVA-HYDROCHLOROTHIAZIDE 25
MG TABLET
HYDROCHLOROTHIAZIDE 00002363968 AVA
AVA-HYDROCHLOROTHIAZIDE 50
MG TABLET
HYDROCHLOROTHIAZIDE 00002363976 AVA
AVA-NORFLOXACIN 400 MG TABLET NORFLOXACIN 00002366304 AVA
CEFAZOLIN 500 MG / VIAL
INJECTION
CEFAZOLIN SODIUM 00002308932 SDZ
CEFAZOLIN 1 G / VIAL INJECTION CEFAZOLIN SODIUM 00002308959 SDZ
CEFAZOLIN 1 G / VIAL INJECTION CEFAZOLIN SODIUM 00002297205 APX
CEFAZOLIN 10 G / VIAL INJECTION CEFAZOLIN SODIUM 00002308967 SDZ
CEFAZOLIN 10 G / VIAL INJECTION CEFAZOLIN SODIUM 00002297213 APX
CO NORFLOXACIN 400 MG TABLET NORFLOXACIN 00002269627 COB
FLAGYL 5 MG / ML INJECTION METRONIDAZOLE 00000870420 BAX
HYDROCHLOROTHIAZIDE 25 MG
TABLET
HYDROCHLOROTHIAZIDE 00002360594 SNS
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012 23
Product(s) Removed from the AHWDBL as Price Policy
Requirements Not Satisfied, continued
Trade Name / Strength / Form Generic Description DIN MFR
HYDROCHLOROTHIAZIDE 50 MG
TABLET
HYDROCHLOROTHIAZIDE 00002360608 SNS
JAMP-PIOGLITAZONE 30 MG TABLET PIOGLITAZONE HCL 00002365529 JPC
JAMP-PIOGLITAZONE 45 MG TABLET PIOGLITAZONE HCL 00002365537 JPC
JAMP-TERBINAFINE 250 MG TABLET TERBINAFINE HCL 00002357070 JPC
MYLAN-ALENDRONATE 10 MG
TABLET
ALENDRONATE SODIUM 00002270129 MYP
MYLAN-CLOBETASOL 0.05% SCALP
LOTION
CLOBETASOL 17-PROPIONATE 00002216213 MYP
MYLAN-CLOBETASOL 0.05%
TOPICAL CREAM
CLOBETASOL 17-PROPIONATE 00002024187 MYP
MYLAN-CLOBETASOL 0.05%
TOPICAL OINTMENT
CLOBETASOL 17-PROPIONATE 00002026767 MYP
MYLAN-TICLOPIDINE 250 MG
TABLET
TICLOPIDINE HCL 00002239744 MYP
NOVO-KETOTIFEN 1 MG TABLET KETOTIFEN FUMARATE 00002230730 TEV
NU-ACEBUTOLOL 100 MG TABLET ACEBUTOLOL HCL 00002165546 NXP
NU-ACEBUTOLOL 200 MG TABLET ACEBUTOLOL HCL 00002165554 NXP
NU-ACEBUTOLOL 400 MG TABLET ACEBUTOLOL HCL 00002165562 NXP
NU-ACYCLOVIR 400 MG TABLET ACYCLOVIR 00002197413 NXP
NU-ACYCLOVIR 800 MG TABLET ACYCLOVIR 00002197421 NXP
NU-AMILZIDE TABLET HYDROCHLOROTHIAZIDE/
AMILORIDE HCL
00000886106 NXP
NU-AMOXI 25 MG / ML ORAL
SUSPENSION
AMOXICILLIN TRIHYDRATE 00000865540 NXP
NU-AMOXI 250 MG CAPSULE AMOXICILLIN TRIHYDRATE 00000865567 NXP
NU-AMOXI 50 MG / ML ORAL
SUSPENSION
AMOXICILLIN TRIHYDRATE 00000865559 NXP
NU-AMOXI 500 MG CAPSULE AMOXICILLIN TRIHYDRATE 00000865575 NXP
NU-BACLO 10 MG TABLET BACLOFEN 00002136090 NXP
NU-BACLO 20 MG TABLET BACLOFEN 00002136104 NXP
NU-BECLOMETHASONE 50 MCG /
DOSE NASAL SPRAY
BECLOMETHASONE
DIPROPIONATE
00002238577 NXP
NU-BUSPIRONE 10MG TABLET BUSPIRONE HCL 00002207672 NXP
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
24 EFFECTIVE JULY 1, 2012
Product(s) Removed from the AHWDBL as Price Policy
Requirements Not Satisfied, continued
Trade Name / Strength / Form Generic Description DIN MFR
NU-CAPTO 100 MG TABLET CAPTOPRIL 00001913859 NXP
NU-CAPTO 12.5 MG TABLET CAPTOPRIL 00001913824 NXP
NU-CAPTO 25 MG TABLET CAPTOPRIL 00001913832 NXP
NU-CAPTO 50 MG TABLET CAPTOPRIL 00001913840 NXP
NU-CARBAMAZEPINE 200 MG
TABLET
CARBAMAZEPINE 00002042568 NXP
NU-CEPHALEX 250 MG TABLET CEPHALEXIN 00000865877 NXP
NU-CEPHALEX 500 MG TABLET CEPHALEXIN 00000865885 NXP
NU-CIMET 300 MG TABLET CIMETIDINE 00000865818 NXP
NU-CIMET 400 MG TABLET CIMETIDINE 00000865826 NXP
NU-CIMET 600 MG TABLET CIMETIDINE 00000865834 NXP
NU-COTRIMOX TABLET SULFAMETHOXAZOLE/
TRIMETHOPRIM
00000865710 NXP
NU-COTRIMOX-DS 800 MG / 160 MG
TABLET
SULFAMETHOXAZOLE/
TRIMETHOPRIM
00000865729 NXP
NU-CYCLOBENZAPRINE 10 MG
TABLET
CYCLOBENZAPRINE HCL 00002171848 NXP
NU-DICLO 25 MG ENTERIC-COATED
TABLET
DICLOFENAC SODIUM 00000886017 NXP
NU-DILTIAZ 30 MG TABLET DILTIAZEM HCL 00000886068 NXP
NU-DILTIAZ 60 MG TABLET DILTIAZEM HCL 00000886076 NXP
NU-DILTIAZ-CD 120 MG
CONTROLLED-DELIVERY CAPSULE
DILTIAZEM HCL 00002231052 NXP
NU-DILTIAZ-CD 180 MG
CONTROLLED-DELIVERY CAPSULE
DILTIAZEM HCL 00002231053 NXP
NU-DILTIAZ-CD 240 MG
CONTROLLED-DELIVERY CAPSULE
DILTIAZEM HCL 00002231054 NXP
NU-DIVALPROEX 125 MG ENTERIC-
COATED TABLET
DIVALPROEX SODIUM
(VALPROIC ACID EQUIV.)
00002239517 NXP
NU-DIVALPROEX 250 MG ENTERIC-
COATED TABLET
DIVALPROEX SODIUM
(VALPROIC ACID EQUIV.)
00002239518 NXP
NU-DIVALPROEX 500 MG ENTERIC-
COATED TABLET
DIVALPROEX SODIUM
(VALPROIC ACID EQUIV.)
00002239519 NXP
NU-DOMPERIDONE 10 MG TABLET DOMPERIDONE MALEATE 00002231477 NXP
NU-DOXYCYCLINE 100 MG CAPSULE DOXYCYCLINE HYCLATE 00002044668 NXP
NU-FAMOTIDINE 20 MG TABLET FAMOTIDINE 00002024195 NXP
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012 25
Product(s) Removed from the AHWDBL as Price Policy
Requirements Not Satisfied, continued
Trade Name / Strength / Form Generic Description DIN MFR
NU-FAMOTIDINE 40 MG TABLET FAMOTIDINE 00002024209 NXP
NU-FLUOXETINE 10 MG CAPSULE FLUOXETINE HCL 00002192756 NXP
NU-FLUOXETINE 20 MG CAPSULE FLUOXETINE HCL 00002192764 NXP
NU-FLURBIPROFEN 100 MG TABLET FLURBIPROFEN 00002020688 NXP
NU-FLURBIPROFEN 50 MG TABLET FLURBIPROFEN 00002020661 NXP
NU-FLUVOXAMINE 50 MG TABLET FLUVOXAMINE MALEATE 00002231192 NXP
NU-FLUVOXAMINE 100 MG TABLET FLUVOXAMINE MALEATE 00002231193 NXP
NU-GEMFIBROZIL 300 MG CAPSULE GEMFIBROZIL 00002058456 NXP
NU-GEMFIBROZIL 600 MG TABLET GEMFIBROZIL 00002058464 NXP
NU-GLYBURIDE 2.5 MG TABLET GLYBURIDE 00002020734 NXP
NU-GLYBURIDE 5 MG TABLET GLYBURIDE 00002020742 NXP
NU-IBUPROFEN 600 MG TABLET IBUPROFEN 00002020726 NXP
NU-INDAPAMIDE 2.5 MG TABLET INDAPAMIDE HEMIHYDRATE 00002223597 NXP
NU-INDO 25 MG CAPSULE INDOMETHACIN 00000865850 NXP
NU-INDO 50 MG CAPSULE INDOMETHACIN 00000865869 NXP
NU-KETOCON 200 MG TABLET KETOCONAZOLE 00002122197 NXP
NU-KETOROLAC 10 MG TABLET KETOROLAC TROMETHAMINE 00002237910 NXP
NU-LEVOCARB 100 MG / 10 MG
TABLET
LEVODOPA/ CARBIDOPA 00002182831 NXP
NU-LEVOCARB 100 MG / 25 MG
TABLET
LEVODOPA/ CARBIDOPA 00002182823 NXP
NU-LEVOCARB 250 MG / 25 MG
TABLET
LEVODOPA / CARBIDOPA 00002182858 NXP
NU-METFORMIN 500 MG TABLET METFORMIN HCL 00002162822 NXP
NU-METFORMIN 850 MG TABLET METFORMIN HCL 00002229517 NXP
NU-METOCLOPRAMIDE 5 MG
TABLET
METOCLOPRAMIDE HCL 00002143275 NXP
NU-METOCLOPRAMIDE 10 MG
TABLET
METOCLOPRAMIDE HCL 00002143283 NXP
NU-METOP 50 MG TABLET METOPROLOL TARTRATE 00000865605 NXP
NU-METOP 100 MG TABLET METOPROLOL TARTRATE 00000865613 NXP
NU-MOCLOBEMIDE 100 MG TABLET MOCLOBEMIDE 00002237111 NXP
NU-NAPROX 250 MG TABLET NAPROXEN 00000865648 NXP
NU-NAPROX 375 MG TABLET NAPROXEN 00000865656 NXP
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
26 EFFECTIVE JULY 1, 2012
Product(s) Removed from the AHWDBL as Price Policy
Requirements Not Satisfied, continued
Trade Name / Strength / Form Generic Description DIN MFR
NU-NAPROX 500 MG TABLET NAPROXEN 00000865664 NXP
NU-NORTRIPTYLINE 10 MG
CAPSULE
NORTRIPTYLINE HCL 00002223139 NXP
NU-NORTRIPTYLINE 25 MG
CAPSULE
NORTRIPTYLINE HCL 00002223147 NXP
NU-OXYBUTYN 5 MG TABLET OXYBUTYNIN CHLORIDE 00002158590 NXP
NU-PEN-VK 300 MG TABLET PRAZOSIN HCL 00000717568 NXP
NU-PINDOL 5 MG TABLET PINDOLOL 00000886149 NXP
NU-PINDOL 10 MG TABLET PINDOLOL 00000886009 NXP
NU-PINDOL 15 MG TABLET PINDOLOL 00000886130 NXP
NU-PIROX 10 MG CAPSULE PIROXICAM 00000865761 NXP
NU-PIROX 20 MG CAPSULE PIROXICAM 00000865788 NXP
NU-PRAZO 1 MG TABLET PRAZOSIN HCL 00001913794 NXP
NU-PRAZO 2 MG TABLET PRAZOSIN HCL 00001913808 NXP
NU-PRAZO 5 MG TABLET PRAZOSIN HCL 00001913816 NXP
NU-RANIT 150 MG TABLET RANITIDINE HCL 00000865737 NXP
NU-RANIT 300 MG TABLET RANITIDINE HCL 00000865745 NXP
NU-SELEGILINE 5 MG TABLET SELEGILINE HCL 00002230717 NXP
NU-SOTALOL 80 MG TABLET SOTALOL HCL 00002200996 NXP
NU-SOTALOL 160 MG TABLET SOTALOL HCL 00002163772 NXP
NU-SUCRALFATE 1 G TABLET SUCRALFATE 00002134829 NXP
NU-SULINDAC 150 MG TABLET SULINDAC 00002042576 NXP
NU-SULINDAC 200 MG TABLET SULINDAC 00002042584 NXP
NU-TERAZOSIN 1 MG TABLET TERAZOSIN HCL 00002233047 NXP
NU-TERAZOSIN 2 MG TABLET TERAZOSIN HCL 00002233048 NXP
NU-TERAZOSIN 5 MG TABLET TERAZOSIN HCL 00002233049 NXP
NU-TERAZOSIN 10 MG TABLET TERAZOSIN HCL 00002233050 NXP
NU-TIAPROFENIC 300 MG TABLET TIAPROFENIC ACID 00002146886 NXP
NU-TICLOPIDINE 250 MG TABLET TICLOPIDINE HCL 00002237560 NXP
NU-TIMOLOL 5 MG TABLET TIMOLOL MALEATE 00002044609 NXP
NU-TIMOLOL 10 MG TABLET TIMOLOL MALEATE 00002044617 NXP
NU-TRAZODONE 50 MG TABLET TRAZODONE HCL 00002165384 NXP
NU-TRAZODONE 100 MG TABLET TRAZODONE HCL 00002165392 NXP
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
EFFECTIVE JULY 1, 2012 27
Product(s) Removed from the AHWDBL as Price Policy
Requirements Not Satisfied, continued
Trade Name / Strength / Form Generic Description DIN MFR
NU-TRAZODONE-D 150 MG TABLET TRAZODONE HCL 00002165406 NXP
NU-TRIAZIDE TABLET HYDROCHLOROTHIAZIDE/
TRIAMTERENE
00000865532 NXP
NU-VALPROIC 250 MG CAPSULE VALPROIC ACID 00002237830 NXP
NU-VERAP 120 MG TABLET VERAPAMIL HCL 00000886041 NXP
NU-VERAP 80 MG TABLET VERAPAMIL HCL 00000886033 NXP
NU-ZOPICLONE 7.5 MG TABLET ZOPICLONE 00002228270 NXP
OCTREOTIDE 100 MCG / ML
INJECTION
OCTREOTIDE ACETATE 00002299437 TEV
OCTREOTIDE 200 MCG / ML
INJECTION
OCTREOTIDE ACETATE 00002299445 TEV
OCTREOTIDE 500 MCG / ML
INJECTION
OCTREOTIDE ACETATE 00002299453 TEV
ONDANSETRON (PRESERVATIVE
FREE) 2 MG / ML INJECTION
ONDANSETRON HCL
DIHYDRATE
00002265524 TEV
ONDANSETRON (PRESERVED) 2 MG
/ ML INJECTION
ONDANSETRON HCL
DIHYDRATE
00002279436 SDZ
ONDANSETRON (UNPRESERVED) 2
MG / ML INJECTION
ONDANSETRON HCL
DIHYDRATE
00002279428 SDZ
ONDANSETRON (WITH
PRESERVATIVE) 2 MG / ML
INJECTION
ONDANSETRON HCL
DIHYDRATE
00002265532 TEV
PMS-BUPROPION SR 100 MG
SUSTAINED-RELEASE TABLET
BUPROPION HCL 00002325373 PMS
PMS-CITALOPRAM 10 MG TABLET CITALOPRAM HYDROBROMIDE 00002270609 PMS
PMS-CLOBETASOL 0.05% SCALP
LOTION
CLOBETASOL 17-PROPIONATE 00002232195 PMS
PMS-CLOBETASOL 0.05% TOPICAL
CREAM
CLOBETASOL 17-PROPIONATE 00002309521 PMS
PMS-CLOBETASOL 0.05% TOPICAL
CREAM
CLOBETASOL 17-PROPIONATE 00002232191 PMS
PMS-CLOBETASOL 0.05% TOPICAL
OINTMENT
CLOBETASOL 17-PROPIONATE 00002309548 PMS
PMS-CLOBETASOL 0.05% TOPICAL
OINTMENT
CLOBETASOL 17-PROPIONATE 00002232193 PMS
RATIO-CLOBETASOL 0.05% SCALP
LOTION
CLOBETASOL 17-PROPIONATE 00001910299 RPH
SUMMARY OF CHANGES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST
28 EFFECTIVE JULY 1, 2012
Product(s) Removed from the AHWDBL as Price Policy
Requirements Not Satisfied, continued
Trade Name / Strength / Form Generic Description DIN MFR
STERILE CEFAZOLIN SODIUM 500
MG / VIAL (BASE) INJECTION
CEFAZOLIN SODIUM 00002108119 TEV
STERILE CEFAZOLIN SODIUM 1 G /
VIAL (BASE) INJECTION
CEFAZOLIN SODIUM 00002108127 TEV
STERILE CEFAZOLIN SODIUM 10 G /
VIAL (BASE) INJECTION
CEFAZOLIN SODIUM 00002108135 TEV
TEVA-HYDRAZIDE 25 MG TABLET HYDROCHLOROTHIAZIDE 00000021474 TEV
TEVA-HYDRAZIDE 50 MG TABLET HYDROCHLOROTHIAZIDE 00000021482 TEV
TICLOPIDINE 250 MG TABLET TICLOPIDINE HCL 00002343045 SNS